Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Oligomeganephronia is a developmental anomaly of the kidneys, and the most severe form of renal hypoplasia, characterized by a reduction of 80% in nephron number and a marked hypertrophy of the glomeruli and tubules.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for oligomeganephronia.
3 publications have been identified in PubMed for oligomeganephronia. Research spans Case Report / Case Series (67%) and Epidemiology / Natural History (33%).
Havens JA (2026). [PMID: 41731920](https://pubmed.ncbi.nlm.nih.gov/41731920/). *Pediatr Dev Pathol*. [Case Report / Case Series]
Bonasoni MP (2025). [PMID: 41225980](https://pubmed.ncbi.nlm.nih.gov/41225980/). *Diagnostics (Basel)*. [Case Report / Case Series]
Buffin-Meyer B (2024). [PMID: 39156164](https://pubmed.ncbi.nlm.nih.gov/39156164/). *Kidney Int Rep*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 7:47 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center